Velocity’s research site in Gaffney was founded in 2005 as part of VitaLink Research and acquired by Velocity in 2021. Our Gaffney site has extensive experience in respiratory, vaccine, migraine, and Internal Medicine studies, and our experienced staff maintains high quality standards and enrollment on all their trials.
Conveniently located on a major highway, the Gaffney site is highly visible and easy to access. The site space is shared with the Principal Investigator’s pulmonary practice, allowing for easy recruitment of established patients of the practice. The Gaffney is also located across the street from the local hospital. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Gaffney team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.